1. Amgen Nederland
Bevat niet: ir | Resultaten tonen met:ir
Maak kennis met Amgen, een wereldwijde pionier op het gebied van biotechnologie die de gezondheidszorg transformeert. Bezoek de website en leer meer over onze innovatieve medicijnen en biotechnologische ontwikkelingen die het leven van miljoenen mensen verbeteren.
2. Amgen | A Worldwide Pioneer in Biotechnology
Investors · Amgen Worldwide · Amgen History · Amgen Continues to Propel...
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
3. Amgen Netherlands: A Worldwide Pioneer in Biotechnology
Bevat niet: ir | Resultaten tonen met:ir
Discover Amgen, a global biotechnology pioneer transforming healthcare. Learn about our innovative medicines and biotech advancements improving lives worldwide.
4. Over ons | Amgen Nederland
Bevat niet: ir | Resultaten tonen met:ir
Als mensen getroffen worden door ziekten, verdienen zij de beste behandeling. Dankzij de ontwikkeling van innovatieve geneesmiddelen is het mogelijk om een steeds beter behandelresultaat te behalen voor hen. Lees en bekijk hoe wij in Nederland ons elke dag inzetten voor betere patiëntzorg.
5. Amgen - NFIA - Invest in Holland
Amgen is committed to helping patients fight serious illnesses, including cancer, kidney, heart and inflammatory disease and osteoporosis.
See Also8 Blocks Is How Many MilesThe story of biotechnology company Amgen in the Netherlands is one of immense growth, thanks to Dutch talent and smart logistics infrastructure.
6. Amgen Europe: A Leading Biopharmaceutical Company in ...
About Amgen · Amgen History · Amgen Foundation · Amgen Contact Information
A biotechnology pioneer, Amgen has grown to be world's leading independent biotech company. We discover, develop, manufacture & deliver human therapeutics.
7. BeiGene Announces Global Strategic Oncology Collaboration with Amgen
Amgen will purchase a 20.5% stake in BeiGene for approximately $2.7 billion in cash at $174.85 per American Depositary Share (ADS).
• Companies to Collaborate on the Commercialization of XGEVA® (denosumab), KYPROLIS® (carfilzomib), and BLINCYTO® (blinatumomab) in China
8. Amgen Pipeline
A robust pipeline leveraging state-of-the-art science and molecular engineering focused on the pursuit of transformative medicines with large effects in ...
A robust pipeline leveraging state-of-the-art science and molecular engineering focused on the pursuit of transformative medicines with large effects in serious diseases. Human genetic validation is used whenever possible to strengthen the evidence base for as many of our programs as possible.
9. Amgen Inc. - AnnualReports.com
Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular ...